Share market update: Pharma shares gain; Glenmark Pharma rises 3%
The Nifty Pharma index was trading 1.14 per cent up at 8143.80.
Share market update: Pharma shares slip; Sun Pharma dips 2%
The Nifty Pharma index was trading 0.8 per cent down at 8056.15 .
Mankind Pharma launches drug for treatment of infertility in India
With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. The company's product is generic version of Abbott's Duphaston tablets, it added. The manufacturing process of Dydrogesterone is very complex as it involves conversion of natural progesterone, the statement said.
The Wadi connection: Technology startups from Israel’s Silicon Wadi have found a fertile ground in India
Technology startups from Israel’s equivalent of Silicon Valley have found a fertile ground in India.
Strides Pharma gets tentative nod from USFDA for pain relieving drug
Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.
Share market update: Pharma shares up; Cipla gains 1%
The Nifty Pharma index was trading 0.14 per cent up at 8055.95.
Share market update: Nifty Pharma index dips; Glenmark Pharma down 2%
The Nifty Pharma index was trading 0.71 per cent down at 8131.70.
Amit Rajan on why pharma MNCs are beating Indian counterparts
Patent protection, ban on fixed dose combinations among factors helping pharma MNCs
Hemang Jani on why telecom, pharma & penny stocks are showing momentum now
FMCG, some private sector banks and even metal names are seeing corrections.
Buy Sun Pharma, price target Rs 475: Shrikant Chouhan
The analyst suggested a stoploss at Rs 438.
Share market update: Nifty Pharma index dips; Piramal Enterprises down 2%
The Nifty Pharma index was trading 0.07 per cent down at 8123.
Sun Pharma gets partial relief from US court in litigation involving three generic drugs
Drug major Sun Pharma is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (District of Massachusetts), alleging a delay in the market entry for three generic drugs -- Valganciclovir, Valsartan and Esomeprazole. The company said it would continue to vigorously defend against all claims.
Buy Sun Pharmaceutical Industries, target Rs 455: Kunal Bothra
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 455.0 and a stoploss at Rs 425 from entry point.
'BUY' or 'SELL' ideas from experts for Wednesday, 4 December, 2019
Piramal Enterprises is a 'Sell' call with a target price of Rs 1650 and a stop loss of Rs 1730.
Look for value in pharma, hospital & PSB midcaps next week: Anand Tandon
Companies which are event driven should be played only by professional traders.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service